 "Dr Reddy's Q4 result: Net profit rises 22% to ₹1,594 cr, dividend declared")
Dr Reddy’s Laboratories on Thursday reported a consolidated net profit of ₹1,593.9 crore for the quarter ended March 31, 2025 (Q4 FY25), marking a 22 per cent increase year-on-year (Y-o-Y) from ₹1,307 crore. Sequentially, profit rose 13 per cent from ₹1,413.3 crore. The company said that new product launches played a key role in achieving double-digit growth in the fourth quarter.
Meanwhile, the pharmaceutical major’s consolidated revenue from operations stood at ₹8,506 crore in Q4 FY25, up 20 per cent from ₹7,083 crore in the same quarter last year. Sequentially, revenue grew 2 per cent from ₹8,358.6 crore in Q3 FY25.
Dr Reddy’s FY25 result
For the entire year, net profit grew marginally by 1.5 per cent to ₹5,654.4 crore from ₹5,568.4 crore in FY24. Moreover, revenue from operations increased from ₹27,916.4 crore in FY24 to ₹32,553.5 crore, registering a 16.6 per cent hike.
Dr Reddy’s Q4 result: Dividend declared
The board of directors have recommended a final dividend of Rs 8 per share, subject to approval of shareholders.
"We achieved double-digit growth across our businesses, driven by successful product launches, increased revenues from key products in the US and the integration of the acquired NRT business. We will continue to strengthen and grow our core businesses through portfolio management and operational excellence, while pursuing strategic partnerships and inorganic growth opportunities," GV Prasad, MD and co-chairman of Dr Reddy’s Lab, said.
Shares of Dr Reddy’s Lab were down 0.67 per cent at ₹1156.40 apiece on the BSE at the close of trading on Friday, ahead of the company's earnings announcement.
Dr Reddy’s Q4 result highlights
Profit: ₹1,593.9 crore
Revenue: ₹8,506 crore
Earnings per share: ₹19.13 (basic) ₹19.11 (diluted)
Dr Reddy’s FY25 result highlights
Profit: ₹5,654.4 crore
Revenue: ₹32,553.5 crore
Earnings per share: ₹67.88 (basic) ₹67.78 (diluted)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%